David Brzostowicki's profile photo

David Brzostowicki

Hollywood

Writer at Medscape

Writer at WebMD

Articles

  • 2 weeks ago | webmd.com | David Brzostowicki

    April 29, 2025 – Prostate cancer is the second-deadliest cancer among U.S. men – and it's on the rise. More than 300,000 men are diagnosed with the condition each year, a number that's been climbing by 3% annually since 2014, according to the American Cancer Society. The reasons come down to a few different things. Screenings have gone up, so more cases are being identified.

  • 1 month ago | webmd.com | David Brzostowicki

    April 3, 2025 – In the U.S. at any given time, thousands of adults and hundreds of children are on waiting lists for a lifesaving heart transplant, facing waits of six months or longer. Some will die in the interim, including one out of every eight children on the list. Worldwide, about 20 people die per day while waiting for any organ.

  • 2 months ago | espanol.medscape.com | David Brzostowicki

    Encuentre las últimas noticias y orientación acerca de la COVID-19 en el Centro de información sobre el coronavirus (SARS-CoV-2).

  • 2 months ago | mdedge.com | David Brzostowicki

    FROM JAMAA new analysis of long-COVID patients has identified five distinct subtypes that researchers say will help doctors diagnose the condition. The new five-type index, developed by federal researchers with the National Institutes of Health’s RECOVER COVID Initiative, identified the most common symptoms in 14,000 people with long COVID, with data from an additional 4000 people added to the updated 2024 index.

  • Jan 8, 2025 | mdedge.com | David Brzostowicki

    A new light therapy device could be a game-changer for millions at risk of vision loss. The Food and Drug Administration (FDA) has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55. Developed by LumiThera, the device showed promising results in a clinical trial, marking it as the first effective therapy for AMD. Approved under the FDA’s “De Novo” process, the treatment offers hope where no similar options existed.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →